Unlock this StockReport nowClick to Unlock

Deltex Medical

DEMG 1.05p 0.0  0.0%
14/12/18 20.0k

Momentum
Relative Strength (%)
1m
3m
1yr
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
vs.
market
vs.
industry
Growth & Value
Margin of Safety (beta)
Screens Passed 1 / 1
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2012 2013 2014 2015 2016 2017 TTM 2018E 2019E CAGR / Avg
Revenue £m
Operating Profit £m
Net Profit £m
EPS Reported p
EPS Normalised p
EPS Growth %
PE Ratio x
PEG x
Profitability
Operating Margin %
ROA %
ROCE %
ROE %
Cashflow
Op. Cashflow ps p
Capex ps p
Free Cashflow ps p
Dividends
Dividend ps p
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc £m
Working Capital £m
Net Fixed Assets £m
Net Debt £m
Book Value £m
Average Shares m
Book Value ps p -19.7%

FINANCIAL BRIEF: For the six months ended 30 June 2018, Deltex Medical Group plc revenues decreased 19% to £2.3M. Net loss increased 9% to £1.2M. Revenues reflect Probes segment decrease of 17% to £2M, Monitors segment decrease of 64% to £86K, United States segment decrease of 28% to £834K, United Kingdom segment decrease of 20% to £782K. Higher net loss reflects Research & Development Expense increase of 12% to £255K (expense). more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score  
E+
E+
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
vs.
market
vs.
industry
Recent History
Latest interim period (ended 30th Jun '18) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2018
31st Dec 2019

Price Target: N/A
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: n/a (£) (p) (£) (£) (p) (£)
Consensus Estimate
1m Change
3m Change
1 brokers Broker Consensus Trend
Broker Recommendations for Deltex Medical
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 0 0 1

Named Brokers and Analysts
Arden Partners Andrew Simms , Edison Investment Research John Savin , Equity Development Emma Ulker , Zeus Capital ,

Profile Summary

Deltex Medical Group plc is a United Kingdom-based haemodynamic management company, which manufactures fluid management devices. The Company's segments are Probes and Other. The Company's Esophageal Doppler Simulator (EDS) enables clinicians to practice probe insertion, focussing and waveform interpretation outside of a patient setting. The Company's CardioQ-EDM and CardioQ-EDM+ esophageal Doppler monitors (EDM) are designed to allow clinicians to guide fluid and drug administration during surgery. The Company's oesophageal Doppler haemodynamic monitoring (ODM) uses ultrasound to measure blood flows in the central circulation of patients, and allows doctors to fine tune the circulation. Its probes include surgical probes, such as I2S and I2P, and critical care probes, such as I2C and EDP240. Its I2S and I2P are used in patients who are anesthetized, sedated or awake. Its EDP240 is used in patients under anesthesia or full sedation. It has operations in Spain and Canada, among others.

Directors: Andy Mears (CEO) 49, Jonathan Shaw (FID) 46, Barry Curtis (SEC) , Nigel Keen (NEC) , Julian Cazalet (NED) , Christopher Jones (NED) 48, Duncan Nichol (NED) , Mark Wippell (NED) 56,

No. of Employees: 85 No. of Shareholders: n/a


Last Annual December 31st, 2017
Last Interim June 30th, 2018
Incorporated January 6, 2000
Public Since August 20, 2001
Shares in Issue 492,663,367
Free Float 170.6m (34.6%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Eligible for an ISA? a SIPP?

DEMG Share Price Performance DEMGQuote
1.05p
0.0  0.0%
Traded 12:02pm · Minimum 15 min delayed · NMS: 20.0k

Latest DEMG News Announcements (delayed)

Upcoming DEMG Events
Thursday 25th April, 2019 (estimate)
Full Year 2018 Deltex Medical Group PLC Earnings Release

Recent ↓
Monday 24th September, 2018
Half Year 2018 Deltex Medical Group PLC Earnings Release
Wednesday 20th June, 2018
Deltex Medical Group PLC Annual Shareholders Meeting
Friday 8th June, 2018 (estimate)
Deltex Medical Group PLC Annual Shareholders Meeting
Friday 27th April, 2018 (estimate)
Full Year 2017 Deltex Medical Group PLC Earnings Release
Friday 9th February, 2018
Deltex Medical Group PLC Ordinary Shareholders Meeting
Monday 11th September, 2017
Half Year 2017 Deltex Medical Group PLC Earnings Call
Monday 11th September, 2017
Half Year 2017 Deltex Medical Group PLC Earnings Release
Friday 9th June, 2017
Deltex Medical Group PLC Annual Shareholders Meeting
Thursday 27th April, 2017
Full Year 2016 Deltex Medical Group PLC Earnings Release
Thursday 13th April, 2017 (estimate)
Full Year 2016 Deltex Medical Group PLC Earnings Release
Thursday 8th September, 2016
Half Year 2016 Deltex Medical Group PLC Earnings Release
Friday 1st July, 2016
Deltex Medical Group PLC Secondary Public Offering Pricing
Tuesday 12th April, 2016
Full Year 2015 Deltex Medical Group PLC Earnings Release
Wednesday 3rd February, 2016
Deltex Medical Group PLC Secondary Public Offering Pricing
Wednesday 3rd February, 2016
Deltex Medical Group PLC Convertible Offering Pricing
Wednesday 3rd February, 2016
Deltex Medical Group PLC Secondary Public Offering Filing
Thursday 2nd October, 2014
Deltex Medical Group PLC at Proactive Investors One2One Investor Forum - London
Friday 12th September, 2014 (estimate)
Interim 2014 Deltex Medical Group PLC Earnings Release
Monday 9th June, 2014
Deltex Medical Group PLC Annual Shareholders Meeting
Monday 9th June, 2014
Deltex Medical Group PLC General Meeting


Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2018.


Should you buy DEMG

Access DEMG Analytics Now!

FREE TRIAL or TAKE THE TOUR
Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis